Zusammenfassung
Hintergrund
Die Wirkung des körpereigenen Hormons Oxytocin und dessen Nützlichkeit für die Schmerztherapie werden in der Forschung über die letzten Jahre vermehrt untersucht und diskutiert. Erste Studienergebnisse konnten bereits die Effekte des Hormons in Bezug auf Geburtsvorgang und Stillen hervorheben. Diverse Tierstudien konnten zudem die Wirksamkeit auf Bindungsverhalten und Schmerzempfinden belegen. Unklar ist allerdings nach wie vor, wie Oxytocin auf das menschliche Schmerzerleben wirkt. Die potenzielle therapeutische Wirksamkeit von Oxytocin könnte für die Primär- und Sekundärversorgung von Schmerzpatienten besonders bedeutsam sein, da es in diesem Bereich verstärkt zu Schmerzchronifizierung kommen kann.
Methoden
Die Datenbanken PubMed, Medline und PsycINFO wurden auf die Begriffe Oxytocin, „pain“, „human“, „analgesic“ durchsucht. Die Suche nach Originalarbeiten ergab insgesamt 89 Artikel, nachdem Studien zu Schmerzen bei Geburt, Stillen und Tierstudien ausgeschlossen worden waren. Es wurden nur Studien eingeschlossen, welche zwischen 1994 und 2015 durchgeführt wurden. Es konnten insgesamt 17 Studien für dieses Review verwendet werden. Davon befassten sich 13 Studien mit der Applikation von Oxytocin und 4 weitere Studien mit der Messung von Oxytocin im Plasma.
Schlussfolgerung
Dieses Review soll einen Überblick über den aktuellen Forschungsstand von Oxytocin und dessen direkten und indirekten Zusammenhang mit dem menschlichen Schmerzerleben geben und die daraus resultierenden Konsequenzen für die multimodale Schmerztherapie hervorheben.
Abstract
Background
Over the years the effect of the neuropeptide oxytocin and its possible utilization for pain management has been increasingly more investigated and discussed. Initial results emphasized the effects of oxytocin with respect to labor and breastfeeding. Diverse animals studies were also able to demonstrate the effectiveness of the peptide in attachment behavior and pain perception; however, it is still unclear how oxytocin affects pain perception in humans. The potential therapeutic effectiveness of oxytocin could be particularly important for primary and secondary treatment of pain patients because chronification of pain can occur more frequently in this area.
Methods
For this review the databases PubMed, Medline und PsycINFO were searched using the terms oxytocin, pain, human and analgesic. The search resulted in a total of 89 original articles after excluding articles regarding labor pain, breastfeeding and animal studies. Only those studies were included which were carried out between 1994 and 2015. A total of 17 articles remained for inclusion in this review and included 13 studies on the exogenous application of oxytocin and 4 on measurement of oxytocin levels in plasma.
Conclusion
This review article gives a summary of the current state of research on oxytocin and its direct and indirect association with human pain perception and emphasizes its relevance for the multimodal management of pain.
Literatur
Alfvén G (2004) Plasma oxytocin in children with recurrent abdominal pain. J Pediatr Gastroenterol Nutr 38(5):513–517
Alfvén G, de la Torre B, Uvnäs-Moberg K (1994) Depressed concentrations of oxytocin and cortisol in children with recurrent abdominal pain of non-organic origin. Acta Paediatr 83(10):1076–1080
Anderberg UM, Uvnäs-Moberg K (2000) Plasma oxytocin levels in female fibromyalgia syndrome patients. Z Rheumatol 59(6):373–379
Arletti R, Benelli A, Bertolini A (1993) Influence of oxytocin on nociception and morphine antinociception. Neuropeptides 24(3):125–129
Arletti R, Bertolini A (1987) Oxytocin acts as an antidepressant in two animal models of depression. Life Sci 41(14):1725–1730
Beckmann H, Lang RE, Gattaz WF (1985) Vasopressin – oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls. Psychoneuroendocrinology 10(2):187–191
Bethlehem RA, van Honk J, Auyeung B, Baron-Cohen S (2013) Oxytocin, brain physiology, and functional connectivity: a review of intranasal oxytocin fMRI studies. Psychoneuroendocrinology 38(7):962–974
Bodnar RJ, Nilaver G, Wallace MM, Badillo-Martinez D, Zimmerman EA (1984) Pain threshold changes in rats following central injection of beta-endorphin, met-enkephalin, vasopressin or oxytocin antisera. Int J Neurosci 24(2):149–160
Bouchon M (2010) Low-dose oxytocin stops unexplained ‘burning’ pain in fibromyalgia: a case report
Breton JD, Veinante P, Uhl-Bronner S, Vergnano AM, Freund-Mercier MJ, Schlichter R, Poisbeau P (2008) Oxytocin-induced antinociception in the spinal cord is mediated by a subpopulation of glutamatergic neurons in lamina I‑II which amplify GABAergic inhibition. Mol Pain 4:19
Cardoso C, Ellenbogen MA, Orlando MA, Bacon SL, Joober R (2013) Intranasal oxytocin attenuates the cortisol response to physical stress: a dose-response study. Psychoneuroendocrinology 38(3):399–407
Carter CS, Grippo AJ, Pournajafi-Nazarloo H, Ruscio MG, Porges SW (2008) Oxytocin, vasopressin and sociality. Prog Brain Res 170:331–336
Crock LW, Kolber BJ, Morgan CD, Sadler KE, Vogt SK, Bruchas MR, Gereau RW (2012) Central amygdala metabotropic glutamate receptor 5 in the modulation of visceral pain. J Neurosci 32(41):14217–14226
Ditzen B, Schaer M, Gabriel B, Bodenmann G, Ehlert U, Heinrichs M (2009) Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict. Biol Psychiatry 65(9):728–731
Eisenach JC, Tong C, Curry R (2015) Phase 1 safety assessment of intrathecal oxytocin. Anesthesiology 122(2):407–413
Eisenberger NI, Way BM, Taylor SE, Welch WT, Lieberman MD (2007) Understanding genetic risk for aggression: clues from the brain’s response to social exclusion. Biol Psychiatry 61(9):1100–1108
Eliava M, Melchior M, Knobloch-Bollmann S, Wahis J, Da Silva Gouveia M, Tang Y, Ciobano AC, Triana del Rio R et al (2016) A new population of parvocellular oxytocin neurons controlling magnocellular neuron activity and inflammatory pain processing. Neuron Accept 89. doi:10.1016/j.neuron.2016.01.041
Frasch A, Zetzsche T, Steiger A, Jirikowski GF (1995) Reduction of plasma oxytocin levels in patients suffering from major depression. Adv Exp Med Biol 395:257–258
Ge Y, Lundeberg T, Yu LC (2002) Blockade effect of mu and kappa opioid antagonists on the anti-nociception induced by intra-periaqueductal grey injection of oxytocin in rats. Brain Res 927(2):204–207
Goodin BR, Ness TJ, Robbins MT (2015) Oxytocin – a multifunctional analgesic for chronic deep tissue pain. Curr Pharm Des 21(7):906–913
Grewen KM, Light KC, Mechlin B, Girdler SS (2008) Ethnicity is associated with alterations in oxytocin relationships to pain sensitivity in women. Ethn Health 13(3):219–241
Holt-Lunstad J, Birmingham WC, Light KC (2014) Relationship quality and oxytocin Influence of stable and modifiable aspects of relationships. J Soc Pers Relat 5(23):0265407514536294
Kessner S, Sprenger C, Wrobel N, Wiech K, Bingel U (2013) Effect of oxytocin on placebo analgesia: a randomized study. JAMA 310(16):1733–1735
Kirsch P, Esslinger C, Chen Q, Mier D, Lis S, Siddhanti S, Gruppe H, Mattay VS, Gallhofer B, Meyer-Lindenberg A (2005) Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci 25(49):11489–11493
Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E (2005) Oxytocin increases trust in humans. Nature 435(7042):673–676
Linkowski P, Geenen V, Kerkhofs M, Mendlewicz J, Legros JJ (1984) Cerebrospinal fluid neurophysins in affective illness and in schizophrenia. Eur Arch Psychiatry Neurol Sci 234(3):162–165
Liu W, Song C, Yang J, Lin B, Wang C (1990) Involvement of oxytocin in spinal cord in acupuncture analgesia. Zhen Ci Yan Jiu 15(1):24–29
Louvel D, Delvaux M, Felez A, Fioramonti J, Bueno L, Lazorthes Y, Frexinos J (1996) Oxytocin increases thresholds of colonic visceral perception in patients with irritable bowel syndrome. Gut 39(5):741–747
Luppi P, Levi-Montalcini R, Bracci-Laudiero L, Bertolini A, Arletti R, Tavernari D, Vigneti E, Aloe L (1993) NGF is released into plasma during human pregnancy: an oxytocin-mediated response? Neuroreport 4(8):1063–1065
Madrazo I, Franco-Bourland RE, León-Meza VM, Mena I (1987) Intraventricular somatostatin-14, arginine vasopressin, and oxytocin: analgesic effect in a patient with intractable cancer pain. Appl Neurophysiol 50(1–6):427–431
Mameli S, Pisanu GM, Sardo S, Marchi A, Pili A, Carboni M, Minerba L, Trincas G, Carta MG, Melis MG, Melis MG (2014) Oxytocin nasal spray in fibromyalgic patients. Rheumatol Int 34(8):1047–1052
Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M (2011) Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci 12(9):524–538
Millan MJ, Schmauss C, Millan MH, Herz A (1984) Vasopressin and oxytocin in the rat spinal cord: analysis of their role in the control of nociception. Brain Res 309(2):384–388
Neumann ID, Krömer SA, Toschi N, Ebner K (2000) Brain oxytocin inhibits the (re)activity of the hypothalamo-pituitary-adrenal axis in male rats: involvement of hypothalamic and limbic brain regions. Regul Pept 96(1–2):31–38
Ohlsson B, Truedsson M, Bengtsson M, Torstenson R, Sjölund K, Björnsson ES, Simrèn M (2005) Effects of long-term treatment with oxytocin in chronic constipation; a double blind, placebo-controlled pilot trial. Neurogastroenterol Motil 17(5):697–704
Paloyelis Y, Krahé C, Maltezos S, Williams SC, Howard MA, Fotopoulou A (2016) The analgesic effect of oxytocin in humans: a double-blinded placebo controlled cross-over study using laser-evoked potentials. J Neuroendocrinol 28. doi:10.1111/jne.12347
Parker KJ, Buckmaster CL, Schatzberg AF, Lyons DM (2005) Intranasal oxytocin administration attenuates the ACTH stress response in monkeys. Psychoneuroendocrinology 30(9):924–929
Petersson M, Alster P, Lundeberg T, Uvnäs-Moberg K (1996) Oxytocin increases nociceptive thresholds in a long-term perspective in female and male rats. Neurosci Lett 212(2):87–90
Petersson M, Hulting AL, Uvnäs-Moberg K (1999) Oxytocin causes a sustained decrease in plasma levels of corticosterone in rats. Neurosci Lett 264(1–3):41–44
Phillips WJ, Ostrovsky O, Galli RL, Dickey S (2006) Relief of acute migraine headache with intravenous oxytocin: report of two cases. J Pain Palliat Care Pharmacother 20(3):25–28
Quevedo AS, Coghill RC (2007) Attentional modulation of spatial integration of pain: evidence for dynamic spatial tuning. J Neurosci 27(43):11635–11640
Rash JA, Aguirre-Camacho A, Campbell TS (2014) Oxytocin and pain: a systematic review and synthesis of findings. Clin J Pain 30(5):453–462
Rash JA, Campbell TS (2014) The effect of intranasal oxytocin administration on acute cold pressor pain: a placebo-controlled, double-blind, within-participants crossover investigation. Psychosom Med 76(6):422–429
Reeta K, Mediratta PK, Rathi N, Jain H, Chugh C, Sharma KK (2006) Role of kappa- and delta-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice. Regul Pept 135(1–2):85–90
Russell JA, Leng G, Bicknell RJ (1995) Opioid tolerance and dependence in the magnocellular oxytocin system: a physiological mechanism? Exp Physiol 80(3):307–340
Schandry R (2006) Biologische Psychologie. Beltz, Weinheim
Schorscher-Petcu A, Sotocinal S, Ciura S, Dupré A, Ritchie J, Sorge RE, Crawley JN, Hu SB, Nishimori K, Young LJ et al (2010) Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1 A receptor in the mouse. J Neurosci 30(24):8274–8284
Singer T, Snozzi R, Bird G, Petrovic P, Silani G, Heinrichs M, Dolan RJ (2008) Effects of oxytocin and prosocial behavior on brain responses to direct and vicariously experienced pain. Emotion 8(6):781–791
Tracy LM, Georgiou-Karistianis N, Gibson SJ, Giummarra MJ (2015) Oxytocin and the modulation of pain experience: implications for chronic pain management. Neurosci Biobehav Rev 55:53–67
Uvnäs-Moberg K, Alster P, Petersson M, Sohlström A, Björkstrand E (1998) Postnatal oxytocin injections cause sustained weight gain and increased nociceptive thresholds in male and female rats. Pediatr Res 43(3):344–348
Uvnäs-Moberg K, Bruzelius G, Alster P, Lundeberg T (1993) The antinociceptive effect of non-noxious sensory stimulation is mediated partly through oxytocinergic mechanisms. Acta Physiol Scand 149(2):199–204
Uvnäs-Moberg K, Eklund M, Hillegaart V, Ahlenius S (2000) Improved conditioned avoidance learning by oxytocin administration in high-emotional male Sprague-Dawley rats. Regul Pept 88(1–3):27–32
Uvnas-Moberg K, Petersson M (2005) Oxytocin, a mediator of anti-stress, well-being, social interaction, growth and healing. Z Psychosom Med Psychother 51(1):57–80
Viero C, Shibuya I, Kitamura N, Verkhratsky A, Fujihara H, Katoh A, Ueta Y, Zingg HH, Chvatal A, Sykova E et al (2010) REVIEW: Oxytocin: crossing the bridge between basic science and pharmacotherapy. CNS Neurosci Ther 16(5:e138–56
Wang YL, Yuan Y, Yang J, Wang CH, Pan YJ, Lu L, Wu YQ, Wang DX, Lv LX, Li RR et al (2013) The interaction between the oxytocin and pain modulation in headache patients. Neuropeptides 47(2):93–97
Windle RJ, Shanks N, Lightman SL, Ingram CD (1997) Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 138(7):2829–2834
Yang J (1994) Intrathecal administration of oxytocin induces analgesia in low back pain involving the endogenous opiate peptide system. Spine 19(8):867–871
Yang J, Li P, Liang JY, Pan YJ, Yan XQ, Yan FL, Hao F, Zhang XY, Zhang J, Zhang J, Zhang J (2011) Oxytocin in the periaqueductal grey regulates nociception in the rat. Regul Pept 169(1–3):39–42
Young LJ, Wang Z (2004) The neurobiology of pair bonding. Nat Neurosci 7(10):1048–1054
Yunus MB, Ahles TA, Aldag JC, Masi AT (1991) Relationship of clinical features with psychological status in primary fibromyalgia. Arthritis Rheum 34(1):15–21
Zunhammer M, Geis S, Busch V, Greenlee MW, Eichhammer P (2015) Effects of intranasal oxytocin on thermal pain in healthy men: a randomized functional magnetic resonance imaging study. Psychosom Med 77(2):156–166
Danksagung
Die Erstellung des Reviews wurde von der privaten Stiftung Psychosomatik der Wirbelsäulenerkrankungen unterstützt.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
A.-C. Pfeifer, B. Ditzen, E. Neubauer und M. Schiltenwolf geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Pfeifer, AC., Ditzen, B., Neubauer, E. et al. Wirkung von Oxytocin auf das menschliche Schmerzerleben. Schmerz 30, 457–469 (2016). https://doi.org/10.1007/s00482-016-0164-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00482-016-0164-z